BACKGROUND: Patient compliance with inhaled corticosteroids (ICS) in asthma is considered to be suboptimal. OBJECTIVES: To describe the patterns of compliance with ICS and identify factors determining the compliance to ICS in adults with asthma. METHODS: Based on a review of the literature and interviews with asthmatic patients who require the regular use of ICS, potential determinants of compliance to ICS were identified. Questionnaires related to these determinants were then administered to a cohort of patients from three subspecialty clinics, including two from university-affiliated centres. Patients with mild-to-moderate asthma who were 15 years of age and older and required (from the physician's point of view) ICS as maintenance medication because of persistent asthma were included in the study. Patients were followed for a period of 12 weeks. Compliance was measured using electronic devices. RESULTS: Data from 124 patients (51 men; mean age 47+/-15 years; mean prescribed daily dose of ICS [fluticasone propionate] 643+/-385 microg) were analyzed. On average, the patients took 72+/-24% of their prescription. Four patterns of compliance were observed and are described: 1A -- regular compliance (n = 29); 1B -- irregular compliance (n = 37); 2A -- regular noncompliance (n = 24); and 2B -- irregular noncompliance (n = 34). Among the potential predictors of noncompliance, age was the only significant predictor (compliance increased with increasing age). There was no difference in asthma control between compliant and noncompliant patients. CONCLUSION: Compliance to ICS in patients with asthma is often suboptimal and difficult to predict. The observations suggest that some asthmatics may be overtreated with ICS.
BACKGROUND:Patient compliance with inhaled corticosteroids (ICS) in asthma is considered to be suboptimal. OBJECTIVES: To describe the patterns of compliance with ICS and identify factors determining the compliance to ICS in adults with asthma. METHODS: Based on a review of the literature and interviews with asthmatic patients who require the regular use of ICS, potential determinants of compliance to ICS were identified. Questionnaires related to these determinants were then administered to a cohort of patients from three subspecialty clinics, including two from university-affiliated centres. Patients with mild-to-moderate asthma who were 15 years of age and older and required (from the physician's point of view) ICS as maintenance medication because of persistent asthma were included in the study. Patients were followed for a period of 12 weeks. Compliance was measured using electronic devices. RESULTS: Data from 124 patients (51 men; mean age 47+/-15 years; mean prescribed daily dose of ICS [fluticasone propionate] 643+/-385 microg) were analyzed. On average, the patients took 72+/-24% of their prescription. Four patterns of compliance were observed and are described: 1A -- regular compliance (n = 29); 1B -- irregular compliance (n = 37); 2A -- regular noncompliance (n = 24); and 2B -- irregular noncompliance (n = 34). Among the potential predictors of noncompliance, age was the only significant predictor (compliance increased with increasing age). There was no difference in asthma control between compliant and noncompliant patients. CONCLUSION: Compliance to ICS in patients with asthma is often suboptimal and difficult to predict. The observations suggest that some asthmatics may be overtreated with ICS.
Authors: Cindy Thamrin; Urs Frey; David A Kaminsky; Helen K Reddel; Andrew J E Seely; Béla Suki; Peter J Sterk Journal: Am J Respir Crit Care Med Date: 2016-11-01 Impact factor: 21.405
Authors: Louis-Philippe Boulet; Allan Becker; Dennis Bowie; Paul Hernandez; Andrew McIvor; Michel Rouleau; Jean Bourbeau; Ian D Graham; Jo Logan; France Légaré; Thomas F Ward; Robert L Cowie; Denis Drouin; Stewart B Harris; Robyn Tamblyn; Pierre Ernst; Wan C Tan; Martyn R Partridge; Philippe Godard; Carla T Herrerias; John W Wilson; Liz Stirling; Emily-Brynn Rozitis; Nancy Garvey; Diane Lougheed; Manon Labrecque; Renata Rea; Martin C Holroyde; Danielle Fagnan; Eileen Dorval; Lisa Pogany; Alan Kaplan; Lisa Cicutto; Mary L Allen; Serge Moraca; J Mark FitzGerald; Francine Borduas Journal: Can Respir J Date: 2006-03 Impact factor: 2.409